Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Rex

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Leukemia|June 1, 2002
Systemic antifungal prophylaxis reduces invasive fungal in acute myelogenous leukemia: a retrospective review of 833 episodes of neutropenia in 322 adultsJ H Rex, E J Anaissie, E Boutati, et al.
Journal of Clinical Microbiology|September 17, 1998
Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologiesM Lozano-Chiu, V L Paetznick, M A Ghannoum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1995
Strain variation and antifungal susceptibility among bloodstream isolates of Candida species from 21 different medical institutionsM A Pfaller, J Rhine-Chalberg, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|May 29, 1999
The trailing end point phenotype in antifungal susceptibility testing is pH dependentK A Marr, T R Rustad, J H Rex, et al.
Journal of Clinical Microbiology|November 24, 1999
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium speciesS Arikan, M Lozano-Chiu, V Paetznick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1996
Human ehrlichiosis causing left ventricular dilatation and dysfunctionN N Vanek, S Kazi, N M Cepero, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 1998
The potential role of cytokine therapy for fungal infections in patients with cancer: is recovery from neutropenia all that is needed?L J Rodriguez-Adrian, M L Grazziutti, J H Rex, et al.
Journal of Clinical Microbiology|February 1, 1992
Sporothrix schenckii fungemia without disseminated sporotrichosisR M Kosinski, P Axelrod, J H Rex, et al.
The Joint Commission Journal on Quality Improvement|October 24, 2000
Systematic root cause analysis of adverse drug events in a tertiary referral hospitalJ H Rex, J E Turnbull, S J Allen, et al.
Journal of Bacteriology|November 1, 1992
Cloning and characterization of a Candida albicans maltase gene involved in sucrose utilizationA Geber, P R Williamson, J H Rex, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Leukemia|June 1, 2002
Systemic antifungal prophylaxis reduces invasive fungal in acute myelogenous leukemia: a retrospective review of 833 episodes of neutropenia in 322 adultsJ H Rex, E J Anaissie, E Boutati, et al.
Journal of Clinical Microbiology|September 17, 1998
Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologiesM Lozano-Chiu, V L Paetznick, M A Ghannoum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1995
Strain variation and antifungal susceptibility among bloodstream isolates of Candida species from 21 different medical institutionsM A Pfaller, J Rhine-Chalberg, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|May 29, 1999
The trailing end point phenotype in antifungal susceptibility testing is pH dependentK A Marr, T R Rustad, J H Rex, et al.
Journal of Clinical Microbiology|November 24, 1999
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium speciesS Arikan, M Lozano-Chiu, V Paetznick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1996
Human ehrlichiosis causing left ventricular dilatation and dysfunctionN N Vanek, S Kazi, N M Cepero, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 1998
The potential role of cytokine therapy for fungal infections in patients with cancer: is recovery from neutropenia all that is needed?L J Rodriguez-Adrian, M L Grazziutti, J H Rex, et al.
Journal of Clinical Microbiology|February 1, 1992
Sporothrix schenckii fungemia without disseminated sporotrichosisR M Kosinski, P Axelrod, J H Rex, et al.
The Joint Commission Journal on Quality Improvement|October 24, 2000
Systematic root cause analysis of adverse drug events in a tertiary referral hospitalJ H Rex, J E Turnbull, S J Allen, et al.
Journal of Bacteriology|November 1, 1992
Cloning and characterization of a Candida albicans maltase gene involved in sucrose utilizationA Geber, P R Williamson, J H Rex, et al.
Pageof 11